QuantoBio

About:

QuantoBio is a developer of reagents for immunology research.

Website: http://www.quantobio.com

Top Investors: TusStar, Jiahao Group, Northeast Securities, Beijing Kanghua Investment, Shanghai Chenshan Investment Management

Description:

QuantoBio creates, manufactures, and conducts scientific research. Their products are clinical diagnostic biological reagents. They developed technological foundations for molecular immunology, luminous biochemistry, cellular immunity, and protein immunity. They offer a variety of goods and services, including functional research and diagnostic reagents based on microRNA expression profiling, as well as microRNA expression profiling and diagnostic reagents. Their clinical products are used for tumour early detection and clinical immune function.These include items from the chemiluminescence series, products for flow cytometry, molecular diagnostics, and protein immunology.